Lilly is engaging in dialogue with government and regulatory authorities to donate bamlanivimab and etesevimab to speed up access and provide treatment options for patients with COVID-19, says the company
Eli Lilly ties up with MSN Labs, Torrent Pharma for sale of Covid-19 drug Baricitnib in India
Baricitinib has received restricted emergency use approval from the health ministry s central drugs standard control organisation for use in combination with Remdesivir for treatment of suspected or confirmed COVID-19 patients
BusinessToday.In | May 13, 2021 | Updated 12:33 IST
Lilly is engaged in active dialogue with regulatory authorities and government to donate anti-COVID-19 treatments
Eli Lilly has signed additional voluntary licences with MSN Labs and Torrent Pharma for manufacturing and sale of Covid-19 drug Baricitnib in India. The pacts with these two companies have been signed after US-based Lilly entered into an agreement with five homegrown pharma companies.